SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-040954
Filing Date
2021-12-09
Accepted
2021-12-09 07:22:31
Documents
15
Period of Report
2021-12-07
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20001613x3_8k.htm   iXBRL 8-K 25516
2 EXHIBIT 99.1 ny20001613x3_99-1.htm EX-99.1 17600
6 image0.jpg GRAPHIC 1083
7 logo_tilray.jpg GRAPHIC 4657
  Complete submission text file 0001140361-21-040954.txt   195174

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20211207.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20211207_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20211207_pre.xml EX-101.PRE 16038
8 EXTRACTED XBRL INSTANCE DOCUMENT ny20001613x3_8k_htm.xml XML 4227
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 211480267
SIC: 2833 Medicinal Chemicals & Botanical Products